Safety Notification Clause Samples
A Safety Notification clause requires parties to promptly inform each other of any safety hazards, incidents, or risks that arise in connection with the contract's subject matter. Typically, this clause outlines the procedures for reporting such issues, including the timeframe for notification and the responsible parties. For example, if a contractor discovers a dangerous condition on a worksite, they must immediately notify the client and take appropriate action. The core function of this clause is to promote a safe environment by ensuring timely communication of safety concerns, thereby reducing the risk of accidents and liability.
POPULAR SAMPLE Copied 1 times
Safety Notification. In case a Product is potentially deviating from the Product Specification, or under any other circumstance where such Product might cause, or already has caused, harm to a patient, user or other person, each Party shall notify the other Party in writing (“Safety Notification”), irrespective of the time or location of detection of the potentially faulty Product, as soon as the respective Party gains knowledge of such. It is CONOR’s sole responsibility to file Medical Device Reports or Vigilance Reports to any legal authority for the Products in order to comply with the applicable laws and regulations in the Territory. Should BIOTRONIK by any applicable law or regulation be obliged to report medical device incidents, this Agreement shall not prevent BIOTRONIK to do so. Safety Notifications and any other complaints on the Products are to be effected to the following address: BIOTRONIK AG CONOR MEDSYSTEMS IRELAND, LTD. Medical Device Safety Officer Medical Safety Officer Ackerstr. 6 ▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, Dublin 2, Ireland ▇▇-▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇ Tel: [*] Tel.: [*] Fax: [*] Fax: [*] CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
Safety Notification. In case a Product is potentially deviating from its Specification, or under any other circumstance where such Product might cause, or already has caused harm to a patient, user or other person, each party shall notify the other party in writing (“Safety Notification”), irrespective of the time or location of detection of the potentially faulty Product, as soon as the respective party gains knowledge of such circumstance. Safety Notifications and any other complaints on the Products are to be effected to the following addresses: BIOMATERIALI Srl, ▇▇. ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ Ricerca s.s.7 per Mesagne ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ (tel. +▇▇ ▇▇▇▇ ▇▇▇ ▇▇▇, Fax: +▇▇ ▇▇▇▇ ▇▇▇ ▇▇▇) email: ▇.▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇.▇▇ ▇▇▇▇▇▇▇ Lifesciences S.L., ▇▇▇. ▇▇▇▇▇ ▇▇▇▇▇▇ Avda. ▇▇▇▇ de la Cierva 27 Parque ▇▇▇▇▇▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇▇▇▇ 46980 Paterna, Valencia Spain (tel. +▇▇ ▇ ▇▇ ▇▇ ▇▇ ▇▇, Fax +▇▇ ▇ ▇▇ ▇▇ ▇▇ ▇▇) email: ▇▇▇▇▇_▇▇▇▇▇▇@▇▇▇▇▇▇▇.▇▇▇
Safety Notification. In case a Product is potentially deviating from the Product Specification, or under any other circumstance where such Product might cause, or already has caused, harm to a patient, user or other person, each Party shall notify the other Party in writing (“Safety Notification”), irrespective of the time or location of detection of the potentially faulty Product, as soon as the respective Party gains knowledge of such. It is SpectraScience’s sole responsibility to file Medical Device Reports or Vigilance Reports to any legal authority for the Products in order to comply with the applicable laws and regulations in the Territory. Should DISTRIBUTOR by any applicable law or regulation be obliged to report medical device incidents, this Agreement shall not prevent DISTRIBUTOR from doing so. Safety Notifications and any other complaints on the Products are to be sent to the following address: SpectraScience, Inc. 1▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇. ▇▇▇▇▇ ▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇ - USA Phone: +▇ ▇▇▇-▇▇▇-▇▇▇▇ Fax: +▇ ▇▇▇-▇▇▇-▇▇▇▇
Safety Notification. In case a Product is suspected of deviating from the Product Specification, or under any other circumstance where such Product might cause, or already has caused harm to a patient, user or other person, each Party shall notify the other Party in writing (“Safety Notification”), irrespective of the time or location of detection of the potentially faulty Product, as soon as the respective Party gains knowledge of such. It is Biotronik’s sole responsibility to file Medical Device Reports or Vigilance Reports to any legal authority for the Products in order to comply with the applicable laws and regulations in the territory. Nothing in this Agreement shall prevent Micrus from also substituting a report of any medical device incident. Safety Notifications and any other complaints on the Products are to be effected to the following address: Micrus Endovascular Corporation Biotronik AG
Safety Notification. ASC agrees to immediately notify CROSLEY in writing upon discovering that any of the products fails to comply with any applicable consumer product or electrical safety or other Federal, state or local law, statute, rule or regulation or contains a defect which could, in the opinion of CROSLEY create a substantial product or electrical hazard and shall supply CROSLEY, in writing, with all information in the possession of ASC concerning the nature and extent of the failure or defect involved.
Safety Notification. Unless otherwise provided in the Safety Data Exchange Agreement entered into by the Parties in relation to the Product, in case a Product might cause, or already has caused harm to a patient, user or other person, each Party shall notify the other Party in writing (such notification, a “Safety Notification”) as soon as the respective Party has knowledge of such. Safety Notifications associated with complaints on Products are to be communicated to the following: by telephone to Primevigilance at [***], with an email copy to [***].
Safety Notification. In case a Product is potentially deviating from its Specification, or under any other circumstance where such Product might cause, or already has caused harm to a patient, user or other person, each party shall notify FOIA CONFIDENTIAL TREATMENT REQUESTED the other party in writing (“Safety Notification”), irrespective of the time or location of detection of the potentially faulty Product, as soon as the respective party gains knowledge of such circumstance. Safety Notifications and any other complaints on the Products are to be effected to the following addresses: BIOMATERIALI Srl, ▇▇. ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ Ricerca s.s.7 per Mesagne ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ (tel. +▇▇ ▇▇▇▇ ▇▇▇ ▇▇▇, Fax: +▇▇ ▇▇▇▇ ▇▇▇ ▇▇▇) email: ▇.▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇.▇▇ ▇▇▇▇▇▇▇ Lifesciences S.L., ▇▇▇. ▇▇▇▇▇ ▇▇▇▇▇▇ Avda. ▇▇▇▇ de la Cierva 27 Parque ▇▇▇▇▇▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇▇▇▇ 46980 Paterna, Valencia Spain (tel. +▇▇ ▇ ▇▇ ▇▇ ▇▇ ▇▇, Fax +▇▇ ▇ ▇▇ ▇▇ ▇▇ ▇▇) email: ▇▇▇▇▇_▇▇▇▇▇▇@▇▇▇▇▇▇▇.▇▇▇